SRZNのPER（株価収益率）は？

Surrozen Inc（SRZN）は現在PER 6.49倍で取引されています。

SRZNのROE（自己資本利益率）は？

Surrozen IncのROEは123.16%です。

SRZNの配当利回りは？

Surrozen Incの配当利回りは0.00%です。

SRZNの品質スコア（Quality Score）は？

当社のAIはSRZNの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。

SRZNは今が買い時ですか？

当社AIのタイミングスコアは100点中27点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。

SRZNはどのセクターに属しますか？

Surrozen IncはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）

SRZN (NASDAQ) 株価分析 | SURROZEN INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-08-03 | FS: 2026-03-31)

SRZN AI Analysis Summary

Our AI summary for SRZN: Surrozen Inc (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 6.49, ROE of 123.16%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 27/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

SRZN

Surrozen Inc

US:NASDAQ STOCK Healthcare >> Biotechnology News 91

USD 21.78

-0.43 (-1.94%) Day Change

Watchlist Portfolio Compare Chart

6.49

P/E

-0.01

D/E

123.2%

ROE

-283.8%

ROA

0.00%

Div Yield

0.15

PEG

SURROZEN INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 21.78 Price -0.43 (-1.94%) Day Change	NEWS SCORE: 91

SRZN, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そしてテクニカルスコアは ...(Sign In to See)...

Loading chart...

31 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is ok , ...

Deepscope 分析

54%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	91
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	21.78
PBV / Sector	-0.93 / 44,219.29
Earning Per Share	-28.93

PE / Sector	6.49 / 19.28 GREAT
PEG or PE/Growth / Sector	0.15 / 1.23 GREAT
Average 1M Daily Value	5.31 M GREAT
Average 1W Daily Value	9.79 M

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-4,571.14 / 98.22
NPM Average (%) / Sector	-2,538.83 / -1,697.63
NPM Change Average (%) / Sector	290.32 / 5,097.97 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-283.79 / 185,260.96
ROA Average (%) / Sector	-156.89 / 36,684.70
ROA Change Average (%) / Sector	86.25 / 422,221.66 GREAT
ROE (%) / Sector	123.16 / 243,762.23 GREAT
ROE Average (%) / Sector	79.90 / 48,758.47 GREAT
ROE Change Average (%) / Sector	-52.87 / 424,968.10
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / 0.04
Dividend Average (%) / Sector	N/A / 17.04
Dividend Change Average (%) / Sector	N/A / -0.19

登録情報

Analyze Date	2026-08-04 08:02:12
Symbol	SRZN
Name	SURROZEN INC
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	11.61 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	257.87 / 9,645.64

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080

Phone: 650 489 9000

Website: https://www.surrozen.com

Sector: Healthcare >> Biotechnology

Description: Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular age-related macular degeneration (wet AMD), and retinopathy indications; SZN-8143, which combines Fzd4 agonism, VEGF antagonism, and interleukin-6, or IL-6 for the treatment of DME/wet AMD/uveitic macular edema; and SZN-413, a Fzd4 targeted bi-specific antibody for the treatment of retinal vascular associated diseases. Surrozen, Inc. has a collaboration and license agreement with Boehringer Ingelheim International GmbH to research, develop, and commercialize Fzd4 bi-specific antibodies; and a research collaboration agreement with TCGFB, Inc. to discover antibody therapeutics targeting transforming growth factor beta, or TGF-ß, for the treatment of patients with idiopathic pulmonary fibrosis. Surrozen, Inc. was founded in 2015 and is headquartered in South San Francisco, California.